Cargando…
Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate
BACKGROUND: The ROX index (ratio of pulse oximetry/FIO(2) to respiratory rate) has been validated to predict high flow nasal cannula therapy (HFNC) outcomes in patients with pneumonia. We evaluated a modified ROX index incorporating heart rate (HR) in patients initiated on HFNC for acute hypoxemic r...
Autores principales: | Goh, Ken Junyang, Chai, Hui Zhong, Ong, Thun How, Sewa, Duu Wen, Phua, Ghee Chee, Tan, Qiao Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310118/ https://www.ncbi.nlm.nih.gov/pubmed/32587703 http://dx.doi.org/10.1186/s40560-020-00458-z |
Ejemplares similares
-
Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis
por: Yau, Chun En, et al.
Publicado: (2023) -
Impact of an Extracorporeal Membrane Oxygenation Intensivist-Led Multidisciplinary Team on Venovenous Extracorporeal Membrane Oxygenation Outcomes
por: Goh, Ken Junyang, et al.
Publicado: (2020) -
Predicting Outcomes of High-Flow Nasal Cannula for Acute Respiratory Distress Syndrome. An Index that ROX
por: Hill, Nicholas S., et al.
Publicado: (2019) -
Potential role of statins in COVID-19
por: Lee, Ken Cheah Hooi, et al.
Publicado: (2020) -
The value of ROX index in predicting the outcome of high flow nasal cannula: a systematic review and meta-analysis
por: Junhai, Zhen, et al.
Publicado: (2022)